Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia.
about
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms.Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.Novel drug therapies in myeloid leukemia.Targeting the mTOR Pathway in Leukemia.
P2860
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia.
@en
type
label
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia.
@en
prefLabel
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia.
@en
P2093
P2860
P50
P1476
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia.
@en
P2093
Alberto M Martelli
Antonino Spartà
Cecilia Evangelisti
Daniela Bressanin
Francesca Chiarini
Marina Soncin
P2860
P304
P356
10.1517/14728222.2013.808333
P407
P577
2013-06-11T00:00:00Z